Literature DB >> 17828400

Is internet information adequate to facilitate surgical decision-making in familial adenomatous polyposis?

Heather B Neuman1, Cynthia Cabral, Mary E Charlson, Larissa K Temple.   

Abstract

PURPOSE: Prophylactic surgery decisions are difficult. Supplemental information improves patients' knowledge, promoting active participation in decision-making. Our objective was to examine internet information regarding prophylactic surgery for familial adenomatous polyposis to determine its adequacy in facilitating patient participation in surgical decision-making.
METHODS: We searched the internet for information on surgery for familial adenomatous polyposis, using an intentionally simple strategy to represent patients' searches. We examined the first 50 sites from each search, assessing each for content by using predefined criteria. Every site was evaluated by two investigators (kappa 0.71) by using the DISCERN criteria, a tool for evaluating quality of health information. Search-efficiency was calculated.
RESULTS: Searches revealed 307,138 "hits"; 20 sites met inclusion criteria. GOOGLE demonstrated the highest search-efficiency (28 percent). Sites were maintained by general health pages (35 percent), hospitals (30 percent), professional organizations (15 percent), familial adenomatous polyposis registries (10 percent), and government (10 percent). Only 40 percent had been developed and/or updated within two years. Most included basic information regarding risk, symptoms, diagnosis, as well as discussion of familial adenomatous polyposis-associated diseases and surveillance (80-100 percent). Although 90 percent of sites presented surgical treatment options, only 60 percent provided details. Few provided information regarding postoperative bowel function (40 percent), sexual function (20 percent), or fertility (5 percent). Seven (35 percent) were identified as being of "good/excellent" quality. Only four were patient-oriented; variable information was provided.
CONCLUSIONS: Internet information regarding surgical treatment of familial adenomatous polyposis is sparse, and insufficient to support active patient participation in decision-making. Despite the time and financial commitment required, development of high-quality internet resources may be justified given the lack of adequate patient-oriented information currently available.

Entities:  

Mesh:

Year:  2007        PMID: 17828400     DOI: 10.1007/s10350-007-9036-z

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

1.  Quality of patient information on the internet for the treatment of anal fistula and anal fissure.

Authors:  F Scott; A Sehgal; A Seghal; H M Joshi; T M Yeung; M P Gosselink
Journal:  Tech Coloproctol       Date:  2014-10-08       Impact factor: 3.781

2.  Feasibility of Providing Web-Based Information to Breast Cancer Patients Prior to a Surgical Consult.

Authors:  Jordan G Bruce; Jennifer L Tucholka; Nicole M Steffens; Jane E Mahoney; Heather B Neuman
Journal:  J Cancer Educ       Date:  2018-10       Impact factor: 2.037

3.  Quality analysis of patient information on surgical treatment of haemorrhoids on the internet.

Authors:  T M Yeung; N D D'Souza
Journal:  Ann R Coll Surg Engl       Date:  2013-07       Impact factor: 1.891

4.  Evaluation of the scope, quality, and health literacy demand of Internet-based anal cancer information.

Authors:  Rebecca Charow; Michelle Snow; Sameera Fathima; Meredith E Giuliani; Kate McEwan; Jordana Winegust; Janet Papadakos
Journal:  J Med Libr Assoc       Date:  2019-10-01

5.  Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity.

Authors:  Yueqiang Jiang; Yanling Ma; RuiChao Li; JianHai Sun
Journal:  Oncotarget       Date:  2017-12-01

6.  Assessment of the quality of patient-oriented information over internet on testicular cancer.

Authors:  Anton S Prasanth; Umesh Jayarajah; Ranganathan Mohanappirian; Sanjeewa A Seneviratne
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.